Haemonetics (NYSE:HAE) announced today that it fully commenced operations at its new manufacturing center in Clinton, Pennsylvania.
Boston-based Haemonetics previously operated at a manufacturing plant in nearby Leetsdale, Pennsylvania, from 1990 until now.
According to a news release, the custom-built facility constitutes approximately 200,000 square feet in Clinton Commerce Park near Pittsburgh International Airport. Initial manufacturing began earlier this year at the site, with Haemonetics making use of both resources from the Leetsdale facility as well as new, advanced technology and manufacturing equipment to support demand for the production of disposables and consumables across its plasma and hospital businesses.
The Clinton facility also includes several environmentally-focused features, including smart controls on the HVAC systems, a recycled compressor heat system for more efficient temperature control and a closed loop process water system that allows for free process cooling during the winter months and reduced chemical treatment needs.
“Haemonetics has been part of the Pittsburgh area for more than 30 years, and our new, state-of-the-art Clinton facility highlights the value we place in this region and the skilled team we’ve developed here,” Haemonetics President and CEO Christopher A. Simon said in the release. “This facility also underscores Haemonetics’ continued focus on operational excellence by investing in the resources we need to ramp up production with a quality-first mindset and deliver for our customers and the donors, patients, collection centers and hospitals counting on our solutions.”